David Hirsch

David Hirsch is a highly accomplished individual with an impressive educational background and extensive experience in the field of healthcare and biotechnology.

David pursued his education at prestigious institutions, obtaining a BA in Biology from The Johns Hopkins University, a PhD in Biology from the Massachusetts Institute of Technology, and an MD from Harvard Medical School.

In addition to his academic achievements, David has held key positions in various organizations, showcasing his leadership and strategic acumen.

He currently serves as the Founder and Managing Director at Longitude Capital, where he plays a pivotal role in investment decisions and strategic direction.

David's professional journey includes past roles such as serving on the Board of Directors for notable companies like Molecular Templates, Tricida Inc., Rapid Micro Biosystems, and many others.

At Amunix Pharmaceuticals, David contributed his expertise as a Board Member, demonstrating his commitment to driving growth and innovation in the pharmaceutical industry.

David's experience extends to positions such as Vice President at Pequot Capital and Engagement Manager at McKinsey & Company, where he honed his skills in finance, strategy, and management.

Throughout his career, David Hirsch has been instrumental in shaping the success of various organizations and has established himself as a respected figure in the biotechnology and healthcare sectors.